Evaluation of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients.
Olivieri
N F
NF
Division of Haematology, Hospital for Sick Children, Toronto, Ontario, Canada.
Templeton
D M
DM
Koren
G
G
Chung
D
D
Hermann
C
C
Freedman
M H
MH
McClelland
R A
RA
D000284:Administration, Oral; D000328:Adult; D000077543:Deferiprone; D003676:Deferoxamine / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000097:blood*; D007502:Iron Chelating Agents; D011728:Pyridones / Q000008:administration & dosage / Q000627:therapeutic use*; D013789:Thalassemia / Q000097:blood / Q000628:therapy*; D065227:Transfusion Reaction
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D007501:Iron; D003676:Deferoxamine